Related Experiment Video
Updated: Jul 4, 2026
Real-time Imaging of Myeloid Cells Dynamics in ApcMin/+ Intestinal Tumors by Spinning Disk Confocal Microscopy
Published on: October 6, 2014
Targeted suppression of beta-catenin blocks intestinal adenoma formation in APC Min mice
Paul J Foley1, Randall P Scheri, Christopher J Smolock
1Department of Surgery, University of Pennsylvania School of Medicine, 3400 Spruce Street, Philadelphia, PA, 19104, USA.
Introduction:
Mutations involving the adenomatous polyposis coli (APC) tumor suppressor gene leading to activation of beta-catenin have been identified in the majority of sporadic colonic adenocarcinomas and in essentially all colonic tumors from patients with Familial Adenomatous Polyposis. The C57BL/6J-APC(min) (Min) mouse, which carries a germ line mutation in the murine homolog of the APC gene is a useful model for intestinal adenoma formation linked to loss of APC activity. One of the critical downstream molecules regulated by APC is beta-catenin; molecular targeting of beta-catenin is, thus, an attractive chemopreventative strategy in colon cancer. Antisense oligodeoxynucleotides (AODNs) capable of downregulating murine beta-catenin have been identified. ANALYSIS OF beta-CATENIN PROTEIN EXPRESSION IN LIVER TISSUE AND INTESTINAL ADENOMAS: Adenomas harvested from mice treated for 7 days with beta-catenin AODNs demonstrated clear downregulation of beta-catenin expression, which was accompanied by a significant reduction in proliferation. There was no effect on proliferation in normal intestinal epithelium. Min mice treated systemically with beta-catenin AODNs over a 6-week period had a statistically significant reduction in the number of intestinal adenomas. These studies provide direct evidence that targeted suppression of beta-catenin inhibits the formation of intestinal adenomas in APC-mutant mice. Furthermore, these studies suggest that molecular targeting of beta-catenin holds significant promise as a chemopreventative strategy in colon cancer.
Insights
Targeting beta-catenin with antisense oligodeoxynucleotides (AODNs) significantly reduced intestinal adenoma formation in APC-mutant mice. This study highlights beta-catenin as a promising target for colon cancer chemoprevention.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Mutations in the adenomatous polyposis coli (APC) gene activate beta-catenin, driving colon cancer development.
- Familial Adenomatous Polyposis and sporadic colon cancers frequently exhibit APC mutations and beta-catenin activation.
- The APC(min) mouse model is crucial for studying intestinal adenoma formation linked to APC loss.
Purpose of the Study:
- To investigate the chemopreventive potential of targeting beta-catenin in APC-mutant mice.
- To evaluate the efficacy of antisense oligodeoxynucleotides (AODNs) in downregulating beta-catenin.
- To assess the impact of beta-catenin suppression on intestinal adenoma development and proliferation.
Main Methods:
- Administration of beta-catenin antisense oligodeoxynucleotides (AODNs) to APC(min) mice.
- Analysis of beta-catenin protein expression in liver tissue and intestinal adenomas.
- Assessment of cell proliferation in normal intestinal epithelium and adenomas.
- Systemic treatment of Min mice over a 6-week period.
Main Results:
- Beta-catenin AODNs treatment led to significant downregulation of beta-catenin expression in adenomas.
- A marked reduction in proliferation was observed in adenomas following beta-catenin AODN treatment.
- No significant effect on proliferation was noted in normal intestinal epithelium.
- Systemic AODN treatment resulted in a statistically significant decrease in the number of intestinal adenomas.
Conclusions:
- Targeted suppression of beta-catenin effectively inhibits intestinal adenoma formation in APC-mutant mice.
- Beta-catenin represents a viable molecular target for colon cancer chemoprevention strategies.
- Antisense oligodeoxynucleotides targeting beta-catenin show promise for preventing colon cancer development.
Related Concept Videos
01:23Catenins
Catenins in Cell Junctions
Catenins bind to cell adhesion molecules such as cadherins and link them to different cytoskeletal proteins depending on the type of cell junction. At the adherens...
01:12Role Of Notch Signalling In Intestinal Stem Cell Renewal
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...